LSPedia, a provider of compliance, traceability, and supply chain software for the pharmaceutical industry, announced a strategic growth investment from Bregal Sagemount through its Basecamp fund. The investment will support LSPedia’s ongoing product innovation, customer expansion, and global growth initiatives.
Founded in 2013 by Riya Cao, LSPedia provides cloud-based software designed to help pharmaceutical manufacturers, wholesale distributors, dispensers, healthcare systems, and government agencies manage the movement and verification of serialized products across increasingly complex supply chains. The platform was built to support serialization and global track-and-trace regulations, including the Drug Supply Chain Security Act (DSCSA), FMD, and other regulatory frameworks across 40 countries.
The company said its platform enables customers to manage compliance requirements, improve operational visibility, and streamline critical supply chain workflows through an integrated solution. LSPedia currently supports more than 1,600 customers and processes over 900 million serialized units annually across a network exceeding 750,000 trading partner connections. The company noted that the scale of its network and transaction volume has positioned it as a critical data and workflow layer across global pharmaceutical supply chains.
As part of its next phase of growth, LSPedia is expanding platform capabilities designed to help customers capture, connect, and act on serialized product data more efficiently across trading partner ecosystems. The company’s flagship solution, OneScan, provides a scan-once workflow that allows stakeholders to capture serialized product events at the point of handling and automatically route the relevant data into appropriate workflows. LSPedia said the platform reduces operational friction while improving real-time supply chain visibility.
The company also highlighted its investments in AI-driven intelligence capabilities, including Traceability AI, aimed at helping customers move beyond regulatory compliance to gain actionable visibility and operational decision support across supply chain activities.
LSPedia stated that the investment from Bregal Sagemount will help accelerate innovation efforts, deepen customer relationships, and expand the company’s global footprint.
Advisors involved in the transaction included Koley Jessen P.C., L.L.O. for LSPedia and Goodwin Procter LLP for Bregal Sagemount.
KEY QUOTES:
“We built LSPedia from the ground up, bootstrapped with a focus on the operational realities of pharmaceutical compliance. Together with Sagemount, we see a significant opportunity to continue expanding the platform, deepening customer relationships, and investing in the next generation of supply chain connectivity and intelligence. With innovations like OneScan and Traceability AI, we’re helping customers achieve supply chain visibility, integration, and predictive insights with the speed and scale today’s environment demands.”
Riya Cao, Founder and CEO, LSPedia
“LSPedia has built a uniquely comprehensive platform that serves participants across the entire pharmaceutical supply chain. The Company’s focus on helping customers meet regulatory requirements while also providing operational value creates a compelling foundation for long-term growth. We are excited to partner with Riya and the team as they accelerate innovation, including advanced traceability and analytics, to support customers worldwide.”
Zuhair Khan, Partner and Co-Head of Basecamp, Bregal Sagemount
